Clinical Trials Directory

Trials / Completed

CompletedNCT02277431

Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms

A Randomized Controlled Trial of a Commercially-Available Probiotic Supplement (Trenev Trio®/Healthy Trinity®) and the Promotion of Normal Gastrointestinal Function Among Adults With Recurrent Gastrointestinal Symptoms

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Participants experiencing recurrent gastrointestinal symptoms in this double-blind, randomized, controlled trial will receive either a commercially-available probiotic dietary supplement or placebo. The investigators hypothesize that participants in the probiotic dietary supplement group will experience greater improvement in their gastrointestinal symptoms than participants in the placebo group.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic dietary supplement (Trenev Trio®)Trenev Trio® (healthcare professional line)/Healthy Trinity® (consumer line) is a dietary supplement that contains probiotics microenrobed in an oil matrix in a two-piece hard gel capsule. One capsule will be taken twice per day (am \& pm) offering a total daily serving of: * Lactobacillus acidophilus NAS super strain (10 billion Colony Forming Units \[CFU\]) * Bifidobacterium bifidum Malyoth super strain (40 billion CFU) * Lactobacillus delbrueckii subspecies bulgaricus LB-51 super strain (10 billion CFU)
DIETARY_SUPPLEMENTplacebo

Timeline

Start date
2014-12-01
Primary completion
2015-09-01
Completion
2015-10-01
First posted
2014-10-29
Last updated
2021-09-14

Source: ClinicalTrials.gov record NCT02277431. Inclusion in this directory is not an endorsement.